Literature DB >> 15316980

A patient with Prader-Willi syndrome and a supernumerary marker chromosome r(15)(q11.1-13p11.1)pat and maternal heterodisomy.

Marion Werner1, Ziva Ben-Neriah, Shira Silverstein, Israela Lerer, Yudith Dagan, Dvorah Abeliovich.   

Abstract

We report on a Prader-Willi patient with a de novo supernumerary marker chromosome (SMC) in 16% of the cells. The SMC was a ring chromosome and it included the PWS/AS critical region as was demonstrated by FISH. Segregation analysis indicated that the SMC originated from a paternal chromosome 15 and the two normal chromosomes 15 of the patients were of the maternal homologues. Namely, the patient had maternal heterodisomy in 85% of the cells and triplication of the PWS/AS region in 15% of the cells. The Prader-Willi features were the result of the low mosaicism of the SMC. The evolution of the maternal heterodisomy and the SMC were two unrelated events, the occurrence of both events in the same embryo rescued it from lethality. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15316980     DOI: 10.1002/ajmg.a.20621

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Characterization of an autism-associated segmental maternal heterodisomy of the chromosome 15q11-13 region.

Authors:  Dorota A Kwasnicka-Crawford; Wendy Roberts; Stephen W Scherer
Journal:  J Autism Dev Disord       Date:  2007-04

2.  Ophthalmic treatment and vision care of a patient with rare ring chromosome 15: a case report.

Authors:  Lidia Puchalska-Niedbał; Stanisław Zajączek; Elżbieta Petriczko; Urszula Kulik
Journal:  Case Rep Pediatr       Date:  2014-06-03

Review 3.  Ring chromosome 15 - cytogenetics and mapping arrays: a case report and review of the literature.

Authors:  César Paz-Y-Miño; Jaime Guevara-Aguirre; Ariane Paz-Y-Miño; Francesca Velarde; Isaac Armendáriz-Castillo; Verónica Yumiceba; Jesús María Hernández; Juan Luis García; Paola E Leone
Journal:  J Med Case Rep       Date:  2018-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.